Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (0.39%), Hang Seng Futures +0.12%, ASX SPI 200 (0.33%), S&P Futures +0.06%

Jun 16 ,2026

  • Synopsis:

    • Asian markets set for negative start to Wednesday trade. Futures signaling pullback in South Korea, mild opening declines in Japan and Australia and flat start in Hong Kong. S&P 500 futures unchanged afterhours. Australian and New Zealand bonds strengthening after Treasury curve bull flattened overnight. Crude recovering following extended selloff to early March lows. Gold and silver little changed. FX markets steady with yen continuing to gravitate around 160-dollar following Tuesday's BOJ rate hike. Bitcoin flat after snapping run of gains.

    • Negative leads for Asian tech with software/memory the main drags on US benchmarks Tuesday. No specific catalyst for the pullback, which follows prior session's rally in wake of US-Iran confirmation of agreement to end conflict. More cautious takes surrounding US-Iran MoU with press highlighting skepticism about how quickly Hormuz flows will normalize and extent to which Iran will make nuclear concessions. Also some semblance of caution ahead of Wednesday's FOMC meeting amid uncertain prospects for further rate cuts.

  • Pre-open Company News:

    • 000564.CH -- CCOOP Group completes equity change procedures and no longer holds any interest in Meilifang Minsheng shopping center

    • 000975.CH -- Shanjin International Gold chair Liu Qin steps down due to work arrangement, effective immediately

    • 300979.CH -- Huali Industrial Group initiated hold at Jefferies

    • ^ASIAREADS -- StreetAccount Asia Reads

    • 6594.JP -- Nidec to delay filing FY25 report; guides Q4 revenue ¥720.00B vs year-ago ¥661.80B and FactSet ¥656.80B [2 est, ¥653.60-659.99B]

    • 500483.IN -- Tata Communications publishes Business Responsibility and Sustainability Report for FY2025-26

    • 533148.IN -- JSW Energy releases sustainability report

    • 600276.CH -- Jiangsu Hengrui Pharmaceuticals obtains NMPA clinical trial approval for SHR-6914 injection for treatment of prostate cancer

    • 530999.IN -- Balaji Amines publishes FY2025-26 annual report including business responsibility & sustainability report beginning on page 94

    • 002460.CH -- Ganfeng Lithium Group discloses disposal of 35.1M shares in PLS Group for A$222M

    • STK.AU -- Strickland Metals holder Jin Huang Mining increases holding to 7.4% from 5.6% -- Form 604

    • 1833.HK -- Ping An Healthcare & Technology CFO Luoqi Zang steps down, effective immediately

    • NBP -- NovaBridge receives FDA Fast Track Designation for Givastomig in first-line HER2-negative metastatic gastric cancer

    • 1628.HK -- Yuzhou Group Holdings to sell Hong Kong office property The Center for HK$268.8M to cut debt

  • On Deck:

    • China:

      • Economic:

        • 08:00 CST: Foreign Direct Investment Y/Y; consensus

    • Hong Kong:

      • Earnings:

        • China High Speed Transmission Equipment Group (658.HK)

    • Japan:

      • Economic:

        • 08:50 JST: Trade Balance NSA (Preliminary); consensus (¥299.3T)

        • 08:50 JST: Import NSA Y/Y (Preliminary); consensus +12.5%

        • 08:50 JST: Export NSA Y/Y (Preliminary); consensus +17.7%

        • 08:50 JST: Core Machinery Orders ex-Electric Power Companies & Ships SA M/M; consensus +3%

    • New Zealand:

      • Economic:

        • 10:45 NZST: Current Account; consensus

  • Market Data:

    • Gold (Aug 26): +$1.90 or +0.04% to $4356.30

    • WTI Crude (Jul 26): +$0.49 or +0.64% to $76.54

    • $-¥: +0.06 or +0.04% to 160.4000

    • $-KRW: (2.30) or (0.15%) to 1511.3000

    • A$-$: (0.00) or (0.11%) to 0.7066

    • $-INR: (0.20) or (0.22%) to 94.2986

    • $-CNY: (0.01) or (0.19%) to 6.7568

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE